Cargando…
Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
BACKGROUND: MyBPC3 mutations are amongst the most frequent causes of hypertrophic cardiomyopathy, however, its prevalence varies between populations. They have been associated with mild and late onset disease expression. Our objectives were to establish the prevalence of MyBPC3 mutations and determi...
Autores principales: | Rodríguez-García, María Isabel, Monserrat, Lorenzo, Ortiz, Martín, Fernández, Xusto, Cazón, Laura, Núñez, Lucía, Barriales-Villa, Roberto, Maneiro, Emilia, Veira, Elena, Castro-Beiras, Alfonso, Hermida-Prieto, Manuel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880974/ https://www.ncbi.nlm.nih.gov/pubmed/20433692 http://dx.doi.org/10.1186/1471-2350-11-67 |
Ejemplares similares
-
Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy
por: Monserrat, Lorenzo, et al.
Publicado: (2011) -
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain
por: García-Giustiniani, Diego, et al.
Publicado: (2015) -
Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings
por: Soler, Rafaela, et al.
Publicado: (2018) -
Storage diseases with hypertrophic cardiomyopathy phenotype
por: Ruiz-Guerrero, Luis, et al.
Publicado: (2018) -
Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis
por: Wasserstrum, Yishay, et al.
Publicado: (2022)